Literature DB >> 27885633

Oligodendrocytes: Development, Physiology and Glucose Metabolism.

Ana I Amaral1, Joana M Tavares1, Ursula Sonnewald2,3, Mark R N Kotter1.   

Abstract

The glutamate-glutamine cycle is an outstanding example of how essential neuronal-glial interactions are for brain function. For several decades, this and other metabolic cycles in the brain have only included neurons and astrocytes but not oligodendrocytes, the myelinating cells of the central nervous system (CNS). Recent data revealed that oligodendrocytes are highly metabolically active cells in the brain and, therefore, should not be ignored. Using 13C-labelled glucose in combination with nuclear magnetic resonance spectroscopy (MRS) and/or mass spectrometry (MS) it is possible to characterize metabolic functions in primary oligodendrocyte cultures. Mature rat oligodendrocytes avidly metabolize glucose in the cytosol and pyruvate derived from glucose in mitochondria. Moreover, they seem to have the ability of performing anaplerosis from pyruvate, which might enable them to synthesize metabolites de novo and transfer them to neighbouring cells. All these original findings highlight the importance of investigating oligodendrocyte metabolism separately from that of astrocytes and neurons to be able to discern the roles played by the individual partners. This is of particular importance in the white matter where the number of oligodendrocytes is considerable. The present book chapter provides some background on oligodendrocyte biology and physiology and summarizes the not very extensive information published on glucose metabolism in oligodendrocytes.

Entities:  

Keywords:  Citrate; Glucose; Glutamate; Glutamine–glutamate cycle; Lactate; Pyruvate carboxylation

Mesh:

Substances:

Year:  2016        PMID: 27885633     DOI: 10.1007/978-3-319-45096-4_10

Source DB:  PubMed          Journal:  Adv Neurobiol


  6 in total

1.  Oleuropein Activates Neonatal Neocortical Proteasomes, but Proteasome Gene Targeting by AAV9 Is Variable in a Clinically Relevant Piglet Model of Brain Hypoxia-Ischemia and Hypothermia.

Authors:  Nagat El Demerdash; May W Chen; Caitlin E O'Brien; Shawn Adams; Ewa Kulikowicz; Lee J Martin; Jennifer K Lee
Journal:  Cells       Date:  2021-08-18       Impact factor: 6.600

2.  Ultrastructural Characterization of Human Oligodendrocytes and Their Progenitor Cells by Pre-embedding Immunogold.

Authors:  María J Ulloa-Navas; Pedro Pérez-Borredá; Raquel Morales-Gallel; Ana Saurí-Tamarit; Patricia García-Tárraga; Antonio J Gutiérrez-Martín; Vicente Herranz-Pérez; Josée M García-Verdugo
Journal:  Front Neuroanat       Date:  2021-06-23       Impact factor: 3.856

Review 3.  Glucose metabolic crosstalk and regulation in brain function and diseases.

Authors:  Shuai Zhang; Brittany Bolduc Lachance; Mark P Mattson; Xiaofeng Jia
Journal:  Prog Neurobiol       Date:  2021-06-10       Impact factor: 10.885

4.  Transcriptomic analysis links diverse hypothalamic cell types to fibroblast growth factor 1-induced sustained diabetes remission.

Authors:  Marie A Bentsen; Dylan M Rausch; Zaman Mirzadeh; Kenjiro Muta; Jarrad M Scarlett; Jenny M Brown; Vicente Herranz-Pérez; Arian F Baquero; Jonatan Thompson; Kimberly M Alonge; Chelsea L Faber; Karl J Kaiyala; Camdin Bennett; Charles Pyke; Cecilia Ratner; Kristoffer L Egerod; Birgitte Holst; Thomas H Meek; Burak Kutlu; Yu Zhang; Thomas Sparso; Kevin L Grove; Gregory J Morton; Birgitte R Kornum; José-Manuel García-Verdugo; Anna Secher; Rasmus Jorgensen; Michael W Schwartz; Tune H Pers
Journal:  Nat Commun       Date:  2020-09-07       Impact factor: 14.919

Review 5.  Oligodendroglial Energy Metabolism and (re)Myelination.

Authors:  Vanja Tepavčević
Journal:  Life (Basel)       Date:  2021-03-13

6.  Conditional Deletion of Foxg1 Alleviates Demyelination and Facilitates Remyelination via the Wnt Signaling Pathway in Cuprizone-Induced Demyelinated Mice.

Authors:  Fuxing Dong; Dajin Liu; Feiyu Jiang; Yaping Liu; Xiuxiang Wu; Xuebin Qu; Jing Liu; Yan Chen; Hongbin Fan; Ruiqin Yao
Journal:  Neurosci Bull       Date:  2020-10-05       Impact factor: 5.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.